论文信息 - 18‐Fluorodeoxyglucose positron emission computed tomography for systemic oxalosis in primary hyperoxaluria type 1

18‐Fluorodeoxyglucose positron emission computed tomography for systemic oxalosis in primary hyperoxaluria type 1

Primary hyperoxaluria type 1 (PH1) is associated with hepatic overproduction of oxalate. Kidneys gradually become unable to eliminate excess oxalate, leading to systemic oxalosis (SO) with deposits in organs.1 When kidney transplantation (KT) becomes necessary, this oxalate load can lead to oxalate nephropathy recurrence. We report the potential interest of 18-FluoroDeoxy-Glucose Positron Emission Computed Tomography (18-FDG-PET/CT) as a tool to assess SO in PH1 patients. Signed informed consent was obtained.

R. Lhommel | A. Devresse | N. Kanaan | N. Godefroid | É. Goffin

[1] E. Sokal,et al. Liver Transplantation in Primary Hyperoxaluria Type 1: We Have to Find an Alternative! , 2021, Transplantation.

[2] J. Lieske,et al. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. , 2021, The New England journal of medicine.

[3] P. Cochat,et al. Transplantation for Primary Hyperoxaluria Type 1: Designing New Strategies in the Era of Promising Therapeutic Perspectives , 2020, Kidney international reports.

[4] F. Somme,et al. Evaluation of Oxalate Osteopathy Secondary to Hyperoxaluria With 18F-FDG PET/CT and 99mTc-HMDP Bone Scan. , 2019, Clinical nuclear medicine.

[5] P. Cochat,et al. Primary hyperoxaluria. , 2013, The New England journal of medicine.